Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache.
Journal
Drugs
ISSN: 1179-1950
Titre abrégé: Drugs
Pays: New Zealand
ID NLM: 7600076
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
7
6
2020
medline:
2
1
2021
entrez:
7
6
2020
Statut:
ppublish
Résumé
Galcanezumab (Emgality
Identifiants
pubmed: 32504377
doi: 10.1007/s40265-020-01329-5
pii: 10.1007/s40265-020-01329-5
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
galcanezumab
55KHL3P693
Calcitonin Gene-Related Peptide
JHB2QIZ69Z
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
893-904Commentaires et corrections
Type : ErratumIn